Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugenia Quiros-Roldan

Showing results (191-200 of 209) with videos related to

Pageof 21
Sort By:
The Journal of Antimicrobial Chemotherapy|April 19, 2018
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trialMassimiliano Fabbiani, Roberta Gagliardini, Nicoletta Ciccarelli, et al.
HIV Medicine|January 7, 2026
Effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV: Data from the COMBINE-2 studyCristina Mussini, Cassidy Henegar, Lambert Assoumou, et al.
Elife|March 2, 2021
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control studyChiara Fallerini, Sergio Daga, Stefania Mantovani, et al.
Plos One|July 17, 2010
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over timeDineke Frentz, Charles A B Boucher, Matthias Assel, et al.
International Journal of Biological Sciences|October 20, 2022
Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2Limin Wang, Julián Candia, Lichun Ma, et al.
Journal of Personalized Medicine|July 2, 2021
Severe COVID-19 in Hospitalized Carriers of Single <i>CFTR</i> Pathogenic VariantsMargherita Baldassarri, Francesca Fava, Chiara Fallerini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2021
CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort StudiesFabienne Caby, Marguerite Guiguet, Laurence Weiss, et al.
Pathogens & Immunity|April 8, 2020
Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective StudyAntonio Muscatello, Silvia Nozza, Massimiliano Fabbiani, et al.
Cell|March 13, 2021
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19Can Liu, Andrew J Martins, William W Lau, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2021
Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunityOttavia M Delmonte, Jenna R E Bergerson, Peter D Burbelo, et al.
Pageof 21

Showing results (191-200 of 209) with videos related to

Sort By:
Pageof 21
The Journal of Antimicrobial Chemotherapy|April 19, 2018
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trialMassimiliano Fabbiani, Roberta Gagliardini, Nicoletta Ciccarelli, et al.
HIV Medicine|January 7, 2026
Effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor in a cohort of virologically suppressed people with HIV: Data from the COMBINE-2 studyCristina Mussini, Cassidy Henegar, Lambert Assoumou, et al.
Elife|March 2, 2021
Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control studyChiara Fallerini, Sergio Daga, Stefania Mantovani, et al.
Plos One|July 17, 2010
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over timeDineke Frentz, Charles A B Boucher, Matthias Assel, et al.
International Journal of Biological Sciences|October 20, 2022
Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2Limin Wang, Julián Candia, Lichun Ma, et al.
Journal of Personalized Medicine|July 2, 2021
Severe COVID-19 in Hospitalized Carriers of Single <i>CFTR</i> Pathogenic VariantsMargherita Baldassarri, Francesca Fava, Chiara Fallerini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2021
CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort StudiesFabienne Caby, Marguerite Guiguet, Laurence Weiss, et al.
Pathogens & Immunity|April 8, 2020
Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective StudyAntonio Muscatello, Silvia Nozza, Massimiliano Fabbiani, et al.
Cell|March 13, 2021
Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19Can Liu, Andrew J Martins, William W Lau, et al.
The Journal of Allergy and Clinical Immunology|September 7, 2021
Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunityOttavia M Delmonte, Jenna R E Bergerson, Peter D Burbelo, et al.
Pageof 21